Nocturia
Information
- Disease name
- Nocturia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00615836 | Completed | Phase 3 | An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults | December 2007 | May 2010 |
| NCT00700583 | Completed | N/A | Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men | May 2008 | June 2008 |
| NCT04480658 | Completed | N/A | Effectiveness of Bryophyllum in Nocturia-Therapy | January 1, 2018 | January 14, 2022 |
| NCT00793819 | Completed | Phase 2 | A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia | January 2009 | October 2009 |
| NCT00824200 | Completed | Phase 4 | Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe) | July 2008 | March 2014 |
| NCT00477490 | Completed | Phase 3 | Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia | May 2007 | February 2008 |
| NCT00879138 | Completed | Phase 1/Phase 2 | Efficacy and Safety of VA106483 in Elderly Males | August 2008 | March 2009 |
| NCT00879216 | Completed | Phase 1 | VA106483 and Alpha Blocker Interaction Study in Elderly Males | April 2009 | July 2009 |
| NCT00902655 | Completed | Phase 4 | Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity | April 2004 | December 2005 |
| NCT00922740 | Completed | Phase 1 | VA106483 Dose Response Study in Elderly Males | June 2009 | September 2009 |
| NCT00937378 | Completed | Phase 3 | Treatment of Patients With Nocturia (Non-PK Study) | June 2009 | August 2010 |
| NCT00937859 | Completed | Phase 3 | Treatment of Patients With Nocturia | June 2009 | July 2010 |
| NCT00981682 | Completed | Phase 3 | Long Term Safety Assessment of SER120 in Patients With Nocturia | August 2009 | August 2011 |
| NCT05597020 | Completed | Phase 4 | A Post Approval Study to Investigate the Efficacy of Daridorexant in Subjects With Insomnia and Comorbid Nocturia | January 18, 2023 | April 18, 2024 |
| NCT01038843 | Completed | Phase 2 | Efficacy Study of VA106483 in Males With Nocturia. | December 2009 | August 2010 |
| NCT01171391 | Completed | Phase 1 | VA106483 Dose Response in Females | July 2010 | November 2010 |
| NCT01184859 | Completed | Phase 2 | Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo | July 2010 | April 2011 |
| NCT01212224 | Completed | A Study of Minirin Melt in Patients With Nocturia | January 2010 | December 2013 | |
| NCT01222598 | Completed | A Study of Minirin Melt in Patients With Nocturia | September 2008 | March 2011 | |
| NCT01223937 | Completed | Phase 3 | Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients | November 2010 | November 2011 |
| NCT01259128 | Completed | Phase 3 | Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia | April 2010 | November 2010 |
| NCT01262456 | Completed | Phase 3 | Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients | February 2011 | January 2012 |
| NCT01330927 | Completed | Phase 1 | Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) | March 2011 | July 2011 |
| NCT01357356 | Completed | Phase 2/Phase 3 | Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia | May 2011 | December 2014 |
| NCT01439997 | Completed | Phase 4 | Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study | March 26, 2012 | February 1, 2015 |
| NCT01486706 | Completed | Phase 2/Phase 3 | Efficacy and Safety of Gabapentin in Treating Overactive Bladder | October 2010 | January 2015 |
| NCT01520948 | Completed | Phase 3 | Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease | September 2012 | August 2017 |
| NCT05464589 | Completed | N/A | Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults | August 10, 2021 | July 25, 2022 |
| NCT01552343 | Completed | Phase 3 | Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary | March 2012 | June 2012 |
| NCT01552395 | Completed | A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia | March 2012 | April 2016 | |
| NCT01576900 | Completed | The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia | April 2012 | October 2014 | |
| NCT01656239 | Completed | Phase 2 | Dose Range Finding Study of Fedovapagon in Men With Nocturia | August 2012 | September 2013 |
| NCT01684800 | Completed | Phase 2 | Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women | September 2012 | June 2013 |
| NCT01694498 | Completed | Phase 2 | Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men | September 2012 | June 2013 |
| NCT05419830 | Completed | N/A | Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses | June 1, 2022 | January 30, 2024 |
| NCT01816724 | Completed | Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia | March 2013 | April 2014 | |
| NCT01900704 | Completed | Phase 3 | Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4 | August 2013 | April 2015 |
| NCT05414279 | Completed | N/A | Validation of Capillary Serum Sodium Levels | April 30, 2021 | October 5, 2021 |
| NCT02068560 | Completed | N/A | The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion | May 2012 | December 2014 |
| NCT02106182 | Completed | Phase 4 | Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia | January 2, 2014 | August 1, 2016 |
| NCT02151253 | Completed | Phase 2/Phase 3 | Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia | May 2011 | September 2015 |
| NCT05368246 | Completed | N/A | Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) | February 15, 2022 | January 15, 2024 |
| NCT04526340 | Completed | N/A | Food and Salt Handling in Diuresis | June 24, 2019 | February 28, 2022 |
| NCT02396160 | Completed | N/A | The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence | August 2013 | May 2015 |
| NCT02410135 | Completed | Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS) | April 2015 | December 2018 | |
| NCT02440841 | Completed | Phase 1 | Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon | May 2015 | July 2015 |
| NCT02637960 | Completed | Phase 2/Phase 3 | Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) | March 2016 | August 2017 |
| NCT02646826 | Completed | Phase 2 | Paxerol™ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial | January 2016 | November 2017 |
| NCT02835846 | Completed | Phase 4 | Investigation of the Effect of the Female Urinary Microbiome on Incontinence | September 2016 | May 2018 |
| NCT02878096 | Completed | Phase 1 | Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study | July 2016 | August 2016 |
| NCT02904759 | Completed | Phase 3 | Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects | September 2016 | September 29, 2017 |
| NCT02905682 | Completed | Phase 3 | Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects | September 2016 | September 27, 2017 |
| NCT05222477 | Completed | N/A | Abdominal Muscle Exercises on Nocturia and Sleep Quality in Women With Type 2 Diabetes | November 15, 2021 | June 1, 2022 |
| NCT04891926 | Completed | N/A | Hormonal Influences on Diuresis | May 1, 2015 | September 30, 2018 |
| NCT03051009 | Completed | Phase 3 | Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects | January 11, 2017 | September 11, 2018 |
| NCT04528784 | Completed | N/A | Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis | October 14, 2020 | March 12, 2021 |
| NCT03201419 | Completed | Phase 2 | A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults | July 27, 2017 | October 31, 2019 |
| NCT03623880 | Completed | N/A | Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders | September 3, 2018 | December 10, 2020 |
| NCT03810027 | Completed | Prevalence and Risk Factors Nocturnal Polyuria in Female OAB | July 1, 2009 | January 31, 2018 | |
| NCT03883724 | Completed | N/A | Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production | February 1, 2019 | November 30, 2021 |
| NCT03928197 | Completed | N/A | Discovering the Effect of Venous Insufficiency on Nocturia (DEVINe) | May 1, 2019 | May 17, 2019 |
| NCT04266496 | Completed | N/A | Discovering the Effect of Venous Insufficiency on Nocturia | January 1, 2020 | May 28, 2021 |
| NCT05298384 | Not yet recruiting | N/A | Pathophysiologic Study to Understand and Possibly Treat Nocturia | August 2024 | November 2024 |
| NCT06110091 | Recruiting | N/A | Multi-center Trial to Improve Nocturia and Sleep in Older Adults | December 5, 2023 | August 2028 |
| NCT04305743 | Recruiting | Phase 4 | Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A | October 9, 2019 | June 1, 2021 |
| NCT04433897 | Recruiting | Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women | June 1, 2018 | December 31, 2025 | |
| NCT05300308 | Recruiting | Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer | January 21, 2022 | January 2025 | |
| NCT05404828 | Recruiting | TUCSON Study: Tackling Underlying Causes Of Sleep Related Nocturia Nocturia | February 28, 2022 | December 31, 2023 | |
| NCT05562388 | Recruiting | N/A | Mandibular Advancement Device and Changes in Nocturia | July 31, 2023 | August 1, 2024 |
| NCT05604222 | Recruiting | Phase 4 | Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women | March 5, 2023 | March 31, 2027 |
| NCT05874375 | Recruiting | N/A | UCon Treatment of Overactive Bladder (OAB) in Males | October 12, 2023 | October 12, 2024 |
| NCT06091566 | Recruiting | N/A | Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) | January 12, 2024 | January 1, 2026 |
| NCT05090722 | Suspended | N/A | A Pilot Study to Evaluate PureWick for Nocturia | December 16, 2021 | October 2024 |
| NCT01530451 | Terminated | Phase 3 | Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients | March 2012 | February 2015 |
| NCT02262936 | Terminated | Phase 2/Phase 3 | Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older | July 2015 | February 2016 |
| NCT03089073 | Terminated | Study of Minirin Melt® in Adult Patients With Nocturia | July 13, 2015 | October 5, 2018 | |
| NCT01779466 | Terminated | Phase 2 | Daytime Impact Sleep Study | April 2013 | June 2014 |
| NCT02359448 | Unknown status | Phase 2 | Melatonin for Nocturia in Parkinson's Disease | April 2015 | December 2015 |
| NCT04357223 | Unknown status | Phase 2 | NOGO for an Overactive Bladder | May 1, 2020 | March 1, 2021 |
| NCT00826527 | Unknown status | Phase 4 | Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP) | January 2007 | |
| NCT03043222 | Withdrawn | N/A | Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men | March 1, 2018 | June 1, 2019 |
| NCT01018225 | Withdrawn | Phase 4 | Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness | November 2009 | July 2010 |
| NCT02961114 | Withdrawn | Phase 1/Phase 2 | Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy | November 1, 2019 | July 2023 |
| NCT02060331 | Withdrawn | Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study | January 2014 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000017
- MeSH unique ID (MeSH (Medical Subject Headings))
- D053158